<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04120064</url>
  </required_header>
  <id_info>
    <org_study_id>PIRB64</org_study_id>
    <nct_id>NCT04120064</nct_id>
  </id_info>
  <brief_title>Treatment of Vitamin D Deficiency With Large Bolus Cholecalciferol</brief_title>
  <official_title>Treatment of Vitamin D Deficiency With Large Bolus Cholecalciferol in the Outpatient Setting</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Parkview Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Parkview Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparing two treatment regimens (solitary large dose vs daily smaller dose) in patients&#xD;
      diagnosed with vitamin D deficiency.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study is looking at patients with diagnosed vitamin D deficiency (&lt;20ng/mL). Participants are&#xD;
      healthy adults between 18 and 75. No diagnosis of cancer, pregnancy, hypercalcemia,&#xD;
      hyperparathyroidism, gastrointestinal absorption disorder, or chronic kidney disease and not&#xD;
      taking medications for seizures or osteoporosis. Participants are randomized into two&#xD;
      treatment groups: (1) 5,000IU cholecalciferol daily or (2) one-time 300,000 international&#xD;
      units (IU) cholecalciferol. Vitamin D level, calcium level, and renal function are measure&#xD;
      one week after initiating treatment and then at 3 months, 6 months, 9 months, and 12 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Covid19, not able to finish recruitment&#xD;
  </why_stopped>
  <start_date type="Actual">January 25, 2019</start_date>
  <completion_date type="Actual">January 15, 2021</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of treatment of vitamin D deficiency over a one year time frame: normalization of vitamin D levels above 30ng/mL</measure>
    <time_frame>12months</time_frame>
    <description>Looking for normalization of vitamin D levels</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of efficacy after starting vitamin D replacement as monitored at one week and then three month intervals for one year</measure>
    <time_frame>1 week, 3 months, 6 months, 9 months, 12 months</time_frame>
    <description>Evaluation of how long participants maintain normal vitamin D levels with treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compliance with therapy as measured by the reported number of missed doses at one week on therapy and then every three months for a year</measure>
    <time_frame>1 week, 3 months, 6 months, 9 months, 12 months</time_frame>
    <description>Evaluation of missed doses</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <arm_group>
    <arm_group_label>Large bolus</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cholecalciferol</intervention_name>
    <description>Large, one time dose of 300,000 IU oral cholecalciferol or daily 5,000 IU oral cholecalciferol</description>
    <arm_group_label>Large bolus</arm_group_label>
    <arm_group_label>Standard</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age 18-75yrs old&#xD;
&#xD;
          -  serum 25(OH)-vitamin D level &lt;20ng/mL&#xD;
&#xD;
          -  patient of Parkview Adult Medicine clinic&#xD;
&#xD;
          -  not currently on cholecalciferol &gt;2,000IU daily&#xD;
&#xD;
          -  no ergocalciferol administration within last week&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  history of hypercalcemia or hyperparathyroidism&#xD;
&#xD;
          -  history of chronic kidney disease with baseline creatinine &gt;1.1&#xD;
&#xD;
          -  history of gastric absorption abnormalities&#xD;
&#xD;
          -  history of Paget's disease or osteomalacia&#xD;
&#xD;
          -  history of thyrotoxicosis&#xD;
&#xD;
          -  known malignancy&#xD;
&#xD;
          -  currently pregnant&#xD;
&#xD;
          -  taking medications for osteoporosis or seizures&#xD;
&#xD;
          -  taking more than 1200mg/day of calcium&#xD;
&#xD;
          -  inpatient hospitalization at the initiation of study meds&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephanie Murphy, DO</last_name>
    <role>Study Chair</role>
    <affiliation>Parkview Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Parkview Medical Center</name>
      <address>
        <city>Pueblo</city>
        <state>Colorado</state>
        <zip>81003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>September 6, 2019</study_first_submitted>
  <study_first_submitted_qc>October 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2019</study_first_posted>
  <last_update_submitted>January 27, 2021</last_update_submitted>
  <last_update_submitted_qc>January 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Parkview Medical Center</investigator_affiliation>
    <investigator_full_name>Doug Duffee</investigator_full_name>
    <investigator_title>Administrator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 23, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04120064/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 23, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/64/NCT04120064/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

